Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
15.23
+0.17 (1.13%)
Jul 21, 2026, 10:10 AM EDT - Market open
Anika Therapeutics Employees
Anika Therapeutics had 235 employees as of December 31, 2025. The number of employees decreased by 53 or -18.40% compared to the previous year.
Employees
235
Change (1Y)
-53
Growth (1Y)
-18.40%
Revenue / Employee
$494,736
Profits / Employee
-$47,077
Market Cap
202.64M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 235 | -53 | -18.40% |
| Dec 31, 2024 | 288 | -69 | -19.33% |
| Dec 31, 2023 | 357 | 12 | 3.48% |
| Dec 31, 2022 | 345 | 48 | 16.16% |
| Dec 31, 2021 | 297 | 20 | 7.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Organigram Global | 1,120 |
| Aurora Cannabis | 1,028 |
| Organogenesis Holdings | 854 |
| Lifecore Biomedical | 382 |
| Evolus | 350 |
| Akebia Therapeutics | 194 |
| ADC Therapeutics | 193 |
| Alpha Teknova | 158 |
ANIK News
- 5 days ago - Anika to Issue Second Quarter 2026 Financial Results on Wednesday, July 29, 2026 - GlobeNewsWire
- 4 weeks ago - Anika Therapeutics Transcript: AGM 2026 - Transcripts
- 6 weeks ago - Anika Therapeutics Proxy statement: Proxy filing - Filings
- 6 weeks ago - Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Anika Therapeutics Proxy statement: Proxy filing - Filings
- 2 months ago - Anika Therapeutics reports Q1 EPS 27c vs.(6c) last year - TheFly
- 2 months ago - Anika Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Anika Therapeutics Earnings release: Q1 2026 - Filings